Cresset’s latest AI-driven software enhances drug discovery by utilizing advanced computational algorithms and robust data analytics. The platform streamlines molecular design and optimization processes, impacting pharmaceutical research significantly. Affected organizations are global biotech firms leveraging AI to improve drug efficacy and safety profiles.
Read More:
- π www.genengnews.com